Study Links Four Sweeteners to Gut Microbiome Shifts

A human trial conducted in 2022 revealed that four widely used sugar alternatives can induce changes in intestinal bacteria. Two of these substances also influenced the body’s glucose response during the experimental period. However, researchers emphasized that the findings do not establish long-term health impacts resulting from these microbial shifts.

Experimental Design and Participants

The study enrolled 120 individuals who had previously avoided products containing sugar substitutes. Researchers divided the participants into six distinct groups. For two weeks, four groups consumed saccharin, sucralose, aspartame, or stevia. A fifth group received packets containing glucose, while the sixth group served as a control by taking no supplements. The quantities of sugar alternatives administered remained below acceptable daily intake limits.

Impact on Glucose Response

Analysis showed that all four substances modified the composition and function of the gut microbiota to varying degrees. Consumption of saccharin and sucralose was specifically linked to a noticeable weakening in glucose response among participants compared to control groups. Individual responses varied significantly. The authors clarified that this result does not imply that consuming either substance causes diabetes or obesity.

Regulatory Safety Assessments

In contrast, the UK National Health Service states that approved sugar substitutes undergo safety evaluations prior to use and are considered acceptable alternatives to sugar. The agency notes that replacing sugary drinks with zero-calorie sweetened options may help reduce energy consumption. Nevertheless, results from studies tracking the effect of these substitutes on weight over longer periods remain inconsistent.

Long-Term Health Implications

Johns Hopkins University confirms that human studies generally indicate the safety of sugar substitutes when consumed within acceptable daily limits. Consequently, the recent findings regarding gut bacteria and glucose response represent short-term indicators. Further research is required to determine whether these changes lead to sustained health effects.